Catalyst Wire Dossier Catalyst Wire Dossier

Siltartoxatug Injection

· Zhuhai Trinomab Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Siltartoxatug Injection, covering 2026-01-06 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury

See pricing